2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $4.7B | $4.6B | $5.3B | $5.6B | $6.1B |
Cost of Revenue | $2B | $1.9B | $1.9B | $2B | $2.2B |
Gross Profit | $2.7B | $2.8B | $3.4B | $3.5B | $3.9B |
Gross Profit % | 58% | 60% | 64% | 64% | 64% |
R&D Expenses | $93M | $97M | $97M | $105M | $127M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | -$1B | -$205M | $268M | $523M | $89M |
Dep. & Amort. | $717M | $585M | $516M | $427M | $421M |
Def. Tax | -$343M | -$218M | $12M | $56M | -$9.8M |
Stock Comp. | $30M | $30M | $196M | $136M | $94M |
Chg. in WC | -$45M | -$232M | $126M | -$86M | -$188M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $308M | $254M | $233M | $247M | $301M |
ST Investments | $0 | $0 | $7.6M | $0.00000012 | $0 |
Cash & ST Inv. | $308M | $254M | $233M | $247M | $301M |
Receivables | $440M | $348M | $435M | $613M | $482M |
Inventory | $678M | $651M | $662M | $853M | $764M |
Coty is experiencing challenges in specific regions and categories, including China, travel retail in Asia, Australia, and U.S. consumer beauty, impacting sales by approximately three points in both prestige and consumer beauty segments.
The company expects cautious retailer inventory management to persist into the second half of fiscal 2025, influencing its prudent guidance, but remains optimistic about strong sellout performance in fragrances.
Coty plans to drive growth in fiscal 2026 through major product launches, distribution expansion in prestige brands, and leveraging growth opportunities in emerging markets and e-commerce.
Gross margin expansion remains a key focus, with a projected 100 basis point improvement for fiscal 2025, alongside disciplined cost management and €120 million in savings initiatives to support EBITDA margin growth to approximately 19%.
The company is committed to outperforming the beauty market long-term, leveraging robust fragrance growth, category expansion (e.g., skincare and prestige color cosmetics), and strategic portfolio evaluation while maintaining flexibility for potential share buybacks or dividends.